Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127241581 | 12724158 | 1 | I | 20160825 | 20160908 | 20160908 | EXP | GB-MHRA-EYC 00144075 | GB-TEVA-688612ACC | TEVA | 0.00 | M | Y | 0.00000 | 20160908 | PH | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127241581 | 12724158 | 1 | PS | BISOPROLOL | BISOPROLOL | 1 | Oral | 2.5 MILLIGRAM DAILY; | Y | U | 19982 | 2.5 | MG | QD | |||||
| 127241581 | 12724158 | 2 | C | CLONAZEPAM. | CLONAZEPAM | 1 | 0 | ||||||||||||
| 127241581 | 12724158 | 3 | C | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | 0 | ||||||||||||
| 127241581 | 12724158 | 4 | C | QUININE | QUININE | 1 | 0 | ||||||||||||
| 127241581 | 12724158 | 5 | C | SENNA | SENNA LEAFSENNOSIDESSENNOSIDES A AND B | 1 | 0 | ||||||||||||
| 127241581 | 12724158 | 6 | C | SIMVASTATIN. | SIMVASTATIN | 1 | 0 | ||||||||||||
| 127241581 | 12724158 | 7 | C | TRAMADOL. | TRAMADOL | 1 | 0 |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127241581 | 12724158 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127241581 | 12724158 | Fall |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |